Literatur
- 1
Chiasson J L. et al. for The STOP-NIDDM Trial Research Group .
Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial.
Lancet.
2002;
359
2072-2077
- 2
Gaede P. et al .
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
N Engl J Med.
2003;
348
383-393
- 3
Lindstrom J. et al. Finnish Diabetes Prevention Study Group .
The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results
on diet and physical activity.
Diabetes Care.
2003;
26
3230-3236
- 4
Knowler W C. et al. Diabetes Prevention Program Research Group .
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
N Engl J Med.
2002;
346
393-403
- 5
Ohkubo Y. et al .
Intensive insulin therapy prevents the progression of diabetic microvascular complications
in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective
5-year study.
Diab Res Clin Pract.
1995;
28
103-117
- 6
Sämann A, Kaiser J, Hunger-Dathe W, Schiel R, Müller U A.
Population-based measurement of quality of diabetes care using HbA1c values in the
state of Thuringia/Germany.
Exp Clin Endocr Diab.
2004;
112
531-537
Prof. Dr. med. U. A. Müller
Funktionsbereich Endokrinologie & Stoffwechselerkrankungen, Klinik für Innere Medizin
III , Universitätsklinkum Jena
07740 Jena
